Here’s why I would be investing $100,000 across CSL Limited (ASX: CSL) and this ASX share in November…
The post Where to invest $100,000 into ASX shares in November appeared first on Motley Fool Australia. –
If you’re in the fortunate position of being in the process of constructing a $100,000 portfolio, you’ll no doubt be on the lookout for investment ideas.
To help you on your way, I have picked out a couple of shares which I think could be excellent options in November.
Here’s why I think investing some of these funds into these ASX shares would be a smart move:
The first share to consider buying with these funds is this biotherapeutics company. I think CSL can be a market beater over the long term thanks largely to its high quality portfolio of therapies. The development of therapies such as Privigen, Hizentra, Idelvion, and Afstyla have helped CSL become the global number one player in a plasma therapies industry worth a massive US$30 billion per year.
In addition to this, its growing portfolio of influenza vaccines means that its Seqirus business is now the number two player in the US$6 billion global influenza vaccines industry. A big positive here is that the COVID-19 pandemic looks set to drive strong demand for influenza vaccines in the coming years, which could see the size of the industry, and therefore Seqirus, grow meaningfully.
But it doesn’t stop there. Every year CSL is investing in the region of 10% to 11% of its sales revenue back into research and development activities. This means that in FY 2021 it will be investing close to US$1 billion into these activities. As you might expect, this has led to CSL having a development pipeline of highly promising therapies and vaccines. Many of which have the potential to generate billions of dollars of sales over the next decade.
In light of the above, I believe CSL is in a great position to maintain its leadership position and continue delivering solid earnings growth over the 2020s and beyond. Overall, I feel this could make it one of the best buy and hold options on the Australian share market today.
Another option for investors to consider buying is Goodman Group. It is one of the world’s leading integrated commercial and industrial property companies with a world class property portfolio which has been expertly curated by management of the last decade.
Goodman’s portfolio comprises strategically located modern, high quality properties in key gateway cities around the world. Management notes that its properties have shortened the distance between businesses and consumers, which it feel this puts its customers ahead of the market. And judging by its customer base, it is hard to argue against this.
Among Goodman’s tenants you will find the likes Amazon, Booktopia, Coles Group Ltd (ASX: COL), DHL, Showpo, and Walmart. Given how the company is at the forefront of commercial property and embracing smart warehouses and robotics, I believe its properties will be in demand for a long time to come. I expect this to underpin solid earnings and dividend growth over the 2020s and beyond.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
- Down 4% in 10 days: Is it time to buy ASX 200 shares?
- These beaten-up shares are about to pick up: Moody’s
- 3 of the best blue chip ASX shares to buy in November
- ASX 200 Weekly Wrap: ASX snaps winning streak… just
- Brokers name 3 ASX shares to buy right now
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of COLESGROUP DEF SET. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Where to invest $100,000 into ASX shares in November appeared first on Motley Fool Australia.